Stephen Kaptoge, Emanuele Di Angelantonio, Gordon Lowe, Mark B Pepys, Simon G Thompson, Rory Collins, John Danesh. Lancet 2010
Times Cited: 1508
Times Cited: 1508
Times Cited
Times Co-cited
Similarity
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.
Paul M Ridker, Brendan M Everett, Tom Thuren, Jean G MacFadyen, William H Chang, Christie Ballantyne, Francisco Fonseca, Jose Nicolau, Wolfgang Koenig, Stefan D Anker,[...]. N Engl J Med 2017
Paul M Ridker, Brendan M Everett, Tom Thuren, Jean G MacFadyen, William H Chang, Christie Ballantyne, Francisco Fonseca, Jose Nicolau, Wolfgang Koenig, Stefan D Anker,[...]. N Engl J Med 2017
26
Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction.
Jean-Claude Tardif, Simon Kouz, David D Waters, Olivier F Bertrand, Rafael Diaz, Aldo P Maggioni, Fausto J Pinto, Reda Ibrahim, Habib Gamra, Ghassan S Kiwan,[...]. N Engl J Med 2019
Jean-Claude Tardif, Simon Kouz, David D Waters, Olivier F Bertrand, Rafael Diaz, Aldo P Maggioni, Fausto J Pinto, Reda Ibrahim, Habib Gamra, Ghassan S Kiwan,[...]. N Engl J Med 2019
17
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.
P M Ridker, M Cushman, M J Stampfer, R P Tracy, C H Hennekens. N Engl J Med 1997
P M Ridker, M Cushman, M J Stampfer, R P Tracy, C H Hennekens. N Engl J Med 1997
15
Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.
Thomas A Pearson, George A Mensah, R Wayne Alexander, Jeffrey L Anderson, Richard O Cannon, Michael Criqui, Yazid Y Fadl, Stephen P Fortmann, Yuling Hong, Gary L Myers,[...]. Circulation 2003
Thomas A Pearson, George A Mensah, R Wayne Alexander, Jeffrey L Anderson, Richard O Cannon, Michael Criqui, Yazid Y Fadl, Stephen P Fortmann, Yuling Hong, Gary L Myers,[...]. Circulation 2003
13
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.
Paul M Ridker, Eleanor Danielson, Francisco A H Fonseca, Jacques Genest, Antonio M Gotto, John J P Kastelein, Wolfgang Koenig, Peter Libby, Alberto J Lorenzatti, Jean G MacFadyen,[...]. N Engl J Med 2008
Paul M Ridker, Eleanor Danielson, Francisco A H Fonseca, Jacques Genest, Antonio M Gotto, John J P Kastelein, Wolfgang Koenig, Peter Libby, Alberto J Lorenzatti, Jean G MacFadyen,[...]. N Engl J Med 2008
12
Low-Dose Methotrexate for the Prevention of Atherosclerotic Events.
Paul M Ridker, Brendan M Everett, Aruna Pradhan, Jean G MacFadyen, Daniel H Solomon, Elaine Zaharris, Virak Mam, Ahmed Hasan, Yves Rosenberg, Erin Iturriaga,[...]. N Engl J Med 2019
Paul M Ridker, Brendan M Everett, Aruna Pradhan, Jean G MacFadyen, Daniel H Solomon, Elaine Zaharris, Virak Mam, Ahmed Hasan, Yves Rosenberg, Erin Iturriaga,[...]. N Engl J Med 2019
10
Colchicine in Patients with Chronic Coronary Disease.
Stefan M Nidorf, Aernoud T L Fiolet, Arend Mosterd, John W Eikelboom, Astrid Schut, Tjerk S J Opstal, Salem H K The, Xiao-Fang Xu, Mark A Ireland, Timo Lenderink,[...]. N Engl J Med 2020
Stefan M Nidorf, Aernoud T L Fiolet, Arend Mosterd, John W Eikelboom, Astrid Schut, Tjerk S J Opstal, Salem H K The, Xiao-Fang Xu, Mark A Ireland, Timo Lenderink,[...]. N Engl J Med 2020
10
Low-dose colchicine for secondary prevention of cardiovascular disease.
Stefan M Nidorf, John W Eikelboom, Charley A Budgeon, Peter L Thompson. J Am Coll Cardiol 2013
Stefan M Nidorf, John W Eikelboom, Charley A Budgeon, Peter L Thompson. J Am Coll Cardiol 2013
9
The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis.
Daniel I Swerdlow, Michael V Holmes, Karoline B Kuchenbaecker, Jorgen E L Engmann, Tina Shah, Reecha Sofat, Yiran Guo, Christina Chung, Anne Peasey, Roman Pfister,[...]. Lancet 2012
Daniel I Swerdlow, Michael V Holmes, Karoline B Kuchenbaecker, Jorgen E L Engmann, Tina Shah, Reecha Sofat, Yiran Guo, Christina Chung, Anne Peasey, Roman Pfister,[...]. Lancet 2012
8
Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS).
Paul M Ridker, Peter Libby, Jean G MacFadyen, Tom Thuren, Christie Ballantyne, Francisco Fonseca, Wolfgang Koenig, Hiroaki Shimokawa, Brendan M Everett, Robert J Glynn. Eur Heart J 2018
Paul M Ridker, Peter Libby, Jean G MacFadyen, Tom Thuren, Christie Ballantyne, Francisco Fonseca, Wolfgang Koenig, Hiroaki Shimokawa, Brendan M Everett, Robert J Glynn. Eur Heart J 2018
8
Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT.
Erin A Bohula, Robert P Giugliano, Christopher P Cannon, Jing Zhou, Sabina A Murphy, Jennifer A White, Andrew M Tershakovec, Michael A Blazing, Eugene Braunwald. Circulation 2015
Erin A Bohula, Robert P Giugliano, Christopher P Cannon, Jing Zhou, Sabina A Murphy, Jennifer A White, Andrew M Tershakovec, Michael A Blazing, Eugene Braunwald. Circulation 2015
7
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial.
Paul M Ridker, Jean G MacFadyen, Brendan M Everett, Peter Libby, Tom Thuren, Robert J Glynn. Lancet 2018
Paul M Ridker, Jean G MacFadyen, Brendan M Everett, Peter Libby, Tom Thuren, Robert J Glynn. Lancet 2018
7
Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation.
Kristiina Rajamäki, Jani Lappalainen, Katariina Oörni, Elina Välimäki, Sampsa Matikainen, Petri T Kovanen, Kari K Eklund. PLoS One 2010
Kristiina Rajamäki, Jani Lappalainen, Katariina Oörni, Elina Välimäki, Sampsa Matikainen, Petri T Kovanen, Kari K Eklund. PLoS One 2010
6
6
Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men.
P M Ridker, N Rifai, M J Stampfer, C H Hennekens. Circulation 2000
P M Ridker, N Rifai, M J Stampfer, C H Hennekens. Circulation 2000
6
C-reactive protein levels and outcomes after statin therapy.
Paul M Ridker, Christopher P Cannon, David Morrow, Nader Rifai, Lynda M Rose, Carolyn H McCabe, Marc A Pfeffer, Eugene Braunwald. N Engl J Med 2005
Paul M Ridker, Christopher P Cannon, David Morrow, Nader Rifai, Lynda M Rose, Carolyn H McCabe, Marc A Pfeffer, Eugene Braunwald. N Engl J Med 2005
6
Obesity and C-reactive protein in various populations: a systematic review and meta-analysis.
J Choi, L Joseph, L Pilote. Obes Rev 2013
J Choi, L Joseph, L Pilote. Obes Rev 2013
6
Chronic inflammation in the etiology of disease across the life span.
David Furman, Judith Campisi, Eric Verdin, Pedro Carrera-Bastos, Sasha Targ, Claudio Franceschi, Luigi Ferrucci, Derek W Gilroy, Alessio Fasano, Gary W Miller,[...]. Nat Med 2019
David Furman, Judith Campisi, Eric Verdin, Pedro Carrera-Bastos, Sasha Targ, Claudio Franceschi, Luigi Ferrucci, Derek W Gilroy, Alessio Fasano, Gary W Miller,[...]. Nat Med 2019
6
Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease.
Renata Micha, Fumiaki Imamura, Moritz Wyler von Ballmoos, Daniel H Solomon, Miguel A Hernán, Paul M Ridker, Dariush Mozaffarian. Am J Cardiol 2011
Renata Micha, Fumiaki Imamura, Moritz Wyler von Ballmoos, Daniel H Solomon, Miguel A Hernán, Paul M Ridker, Dariush Mozaffarian. Am J Cardiol 2011
5
5
Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data.
Frances Wensley, Pei Gao, Stephen Burgess, Stephen Kaptoge, Emanuele Di Angelantonio, Tina Shah, James C Engert, Robert Clarke, George Davey-Smith, Børge G Nordestgaard,[...]. BMJ 2011
Frances Wensley, Pei Gao, Stephen Burgess, Stephen Kaptoge, Emanuele Di Angelantonio, Tina Shah, James C Engert, Robert Clarke, George Davey-Smith, Børge G Nordestgaard,[...]. BMJ 2011
5
Bias in meta-analysis detected by a simple, graphical test.
M Egger, G Davey Smith, M Schneider, C Minder. BMJ 1997
M Egger, G Davey Smith, M Schneider, C Minder. BMJ 1997
5
Inflammation, Immunity, and Infection in Atherothrombosis: JACC Review Topic of the Week.
Peter Libby, Joseph Loscalzo, Paul M Ridker, Michael E Farkouh, Priscilla Y Hsue, Valentin Fuster, Ahmed A Hasan, Salomon Amar. J Am Coll Cardiol 2018
Peter Libby, Joseph Loscalzo, Paul M Ridker, Michael E Farkouh, Priscilla Y Hsue, Valentin Fuster, Ahmed A Hasan, Salomon Amar. J Am Coll Cardiol 2018
5
Progress and challenges in translating the biology of atherosclerosis.
Peter Libby, Paul M Ridker, Göran K Hansson. Nature 2011
Peter Libby, Paul M Ridker, Göran K Hansson. Nature 2011
5
Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis.
Stephen Kaptoge, Sreenivasa Rao Kondapally Seshasai, Pei Gao, Daniel F Freitag, Adam S Butterworth, Anders Borglykke, Emanuele Di Angelantonio, Vilmundur Gudnason, Ann Rumley, Gordon D O Lowe,[...]. Eur Heart J 2014
Stephen Kaptoge, Sreenivasa Rao Kondapally Seshasai, Pei Gao, Daniel F Freitag, Adam S Butterworth, Anders Borglykke, Emanuele Di Angelantonio, Vilmundur Gudnason, Ann Rumley, Gordon D O Lowe,[...]. Eur Heart J 2014
5
Anti-inflammatory approaches to ischaemic stroke prevention.
Peter J Kelly, Sean Murphy, Sarah Coveney, Francisco Purroy, Robin Lemmens, Georgios Tsivgoulis, Chris Price. J Neurol Neurosurg Psychiatry 2018
Peter J Kelly, Sean Murphy, Sarah Coveney, Francisco Purroy, Robin Lemmens, Georgios Tsivgoulis, Chris Price. J Neurol Neurosurg Psychiatry 2018
14
IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial.
Paul M Ridker, Matt Devalaraja, Florian M M Baeres, Mads D M Engelmann, G Kees Hovingh, Milana Ivkovic, Larry Lo, Douglas Kling, Pablo Pergola, Dominic Raj,[...]. Lancet 2021
Paul M Ridker, Matt Devalaraja, Florian M M Baeres, Mads D M Engelmann, G Kees Hovingh, Milana Ivkovic, Larry Lo, Douglas Kling, Pablo Pergola, Dominic Raj,[...]. Lancet 2021
7
Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial.
Michelle L O'Donoghue, Eugene Braunwald, Harvey D White, Mary Ann Lukas, Elizabeth Tarka, P Gabriel Steg, Judith S Hochman, Christoph Bode, Aldo P Maggioni, KyungAh Im,[...]. JAMA 2014
Michelle L O'Donoghue, Eugene Braunwald, Harvey D White, Mary Ann Lukas, Elizabeth Tarka, P Gabriel Steg, Judith S Hochman, Christoph Bode, Aldo P Maggioni, KyungAh Im,[...]. JAMA 2014
4
Hs-CRP and all-cause, cardiovascular, and cancer mortality risk: A meta-analysis.
Yunwei Li, Xiaoming Zhong, Guanchang Cheng, Cuihua Zhao, Lei Zhang, Yan Hong, Qilin Wan, Ruili He, Zhizhong Wang. Atherosclerosis 2017
Yunwei Li, Xiaoming Zhong, Guanchang Cheng, Cuihua Zhao, Lei Zhang, Yan Hong, Qilin Wan, Ruili He, Zhizhong Wang. Atherosclerosis 2017
4
Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association.
Emelia J Benjamin, Paul Muntner, Alvaro Alonso, Marcio S Bittencourt, Clifton W Callaway, April P Carson, Alanna M Chamberlain, Alexander R Chang, Susan Cheng, Sandeep R Das,[...]. Circulation 2019
Emelia J Benjamin, Paul Muntner, Alvaro Alonso, Marcio S Bittencourt, Clifton W Callaway, April P Carson, Alanna M Chamberlain, Alexander R Chang, Susan Cheng, Sandeep R Das,[...]. Circulation 2019
4
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.
Christopher P Cannon, Michael A Blazing, Robert P Giugliano, Amy McCagg, Jennifer A White, Pierre Theroux, Harald Darius, Basil S Lewis, Ton Oude Ophuis, J Wouter Jukema,[...]. N Engl J Med 2015
Christopher P Cannon, Michael A Blazing, Robert P Giugliano, Amy McCagg, Jennifer A White, Pierre Theroux, Harald Darius, Basil S Lewis, Ton Oude Ophuis, J Wouter Jukema,[...]. N Engl J Med 2015
4
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals.
Peter Duewell, Hajime Kono, Katey J Rayner, Cherilyn M Sirois, Gregory Vladimer, Franz G Bauernfeind, George S Abela, Luigi Franchi, Gabriel Nuñez, Max Schnurr,[...]. Nature 2010
Peter Duewell, Hajime Kono, Katey J Rayner, Cherilyn M Sirois, Gregory Vladimer, Franz G Bauernfeind, George S Abela, Luigi Franchi, Gabriel Nuñez, Max Schnurr,[...]. Nature 2010
4
Colchicine Attenuates Inflammation Beyond the Inflammasome in Chronic Coronary Artery Disease: A LoDoCo2 Proteomic Substudy.
Tjerk S J Opstal, Renate M Hoogeveen, Aernoud T L Fiolet, Max J M Silvis, Salem H K The, Willem A Bax, Dominique P V de Kleijn, Arend Mosterd, Erik S G Stroes, Jan H Cornel. Circulation 2020
Tjerk S J Opstal, Renate M Hoogeveen, Aernoud T L Fiolet, Max J M Silvis, Salem H K The, Willem A Bax, Dominique P V de Kleijn, Arend Mosterd, Erik S G Stroes, Jan H Cornel. Circulation 2020
8
Colchicine--Update on mechanisms of action and therapeutic uses.
Ying Ying Leung, Laura Li Yao Hui, Virginia B Kraus. Semin Arthritis Rheum 2015
Ying Ying Leung, Laura Li Yao Hui, Virginia B Kraus. Semin Arthritis Rheum 2015
4
Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review.
John Danesh, Stephen Kaptoge, Andrea G Mann, Nadeem Sarwar, Angela Wood, Sara B Angleman, Frances Wensley, Julian P T Higgins, Lucy Lennon, Gudny Eiriksdottir,[...]. PLoS Med 2008
John Danesh, Stephen Kaptoge, Andrea G Mann, Nadeem Sarwar, Angela Wood, Sara B Angleman, Frances Wensley, Julian P T Higgins, Lucy Lennon, Gudny Eiriksdottir,[...]. PLoS Med 2008
4
C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease.
John Danesh, Jeremy G Wheeler, Gideon M Hirschfield, Shinichi Eda, Gudny Eiriksdottir, Ann Rumley, Gordon D O Lowe, Mark B Pepys, Vilmundur Gudnason. N Engl J Med 2004
John Danesh, Jeremy G Wheeler, Gideon M Hirschfield, Shinichi Eda, Gudny Eiriksdottir, Ann Rumley, Gordon D O Lowe, Mark B Pepys, Vilmundur Gudnason. N Engl J Med 2004
4
Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
M Bryant Howren, Donald M Lamkin, Jerry Suls. Psychosom Med 2009
M Bryant Howren, Donald M Lamkin, Jerry Suls. Psychosom Med 2009
4
From C-Reactive Protein to Interleukin-6 to Interleukin-1: Moving Upstream To Identify Novel Targets for Atheroprotection.
Paul M Ridker. Circ Res 2016
Paul M Ridker. Circ Res 2016
4
Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
. Lancet 2020
. Lancet 2020
4
High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link?
Omair Yousuf, Bibhu D Mohanty, Seth S Martin, Parag H Joshi, Michael J Blaha, Khurram Nasir, Roger S Blumenthal, Matthew J Budoff. J Am Coll Cardiol 2013
Omair Yousuf, Bibhu D Mohanty, Seth S Martin, Parag H Joshi, Michael J Blaha, Khurram Nasir, Roger S Blumenthal, Matthew J Budoff. J Am Coll Cardiol 2013
4
Anticytokine Agents: Targeting Interleukin Signaling Pathways for the Treatment of Atherothrombosis
Paul M Ridker. Circ Res 2019
Paul M Ridker. Circ Res 2019
4
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.
P M Ridker, C H Hennekens, J E Buring, N Rifai. N Engl J Med 2000
P M Ridker, C H Hennekens, J E Buring, N Rifai. N Engl J Med 2000
4
Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies.
Alexander Thompson, Pei Gao, Lia Orfei, Sarah Watson, Emanuele Di Angelantonio, Stephen Kaptoge, Christie Ballantyne, Christopher P Cannon, Michael Criqui, Mary Cushman,[...]. Lancet 2010
Alexander Thompson, Pei Gao, Lia Orfei, Sarah Watson, Emanuele Di Angelantonio, Stephen Kaptoge, Christie Ballantyne, Christopher P Cannon, Michael Criqui, Mary Cushman,[...]. Lancet 2010
3
Cytokines in atherosclerosis: pathogenic and regulatory pathways.
Alain Tedgui, Ziad Mallat. Physiol Rev 2006
Alain Tedgui, Ziad Mallat. Physiol Rev 2006
3
Immune and inflammatory mechanisms of atherosclerosis (*).
Elena Galkina, Klaus Ley. Annu Rev Immunol 2009
Elena Galkina, Klaus Ley. Annu Rev Immunol 2009
3
Darapladib for preventing ischemic events in stable coronary heart disease.
Harvey D White, Claes Held, Ralph Stewart, Elizabeth Tarka, Rebekkah Brown, Richard Y Davies, Andrzej Budaj, Robert A Harrington, P Gabriel Steg, Diego Ardissino,[...]. N Engl J Med 2014
Harvey D White, Claes Held, Ralph Stewart, Elizabeth Tarka, Rebekkah Brown, Richard Y Davies, Andrzej Budaj, Robert A Harrington, P Gabriel Steg, Diego Ardissino,[...]. N Engl J Med 2014
3
Systematic Review and Meta-Analysis of the Association Between C-Reactive Protein and Major Cardiovascular Events in Patients with Peripheral Artery Disease.
T P Singh, D R Morris, S Smith, J V Moxon, J Golledge. Eur J Vasc Endovasc Surg 2017
T P Singh, D R Morris, S Smith, J V Moxon, J Golledge. Eur J Vasc Endovasc Surg 2017
6
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.